Authors' reply to Cunningham and Messerli and colleagues

BMJ. 2016 Jun 7:353:i3141. doi: 10.1136/bmj.i3141.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenergic beta-Antagonists* / administration & dosage
  • Adrenergic beta-Antagonists* / adverse effects
  • Aged
  • Drug-Related Side Effects and Adverse Reactions* / etiology
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Heart Failure / drug therapy*
  • Humans
  • Risk Assessment

Substances

  • Adrenergic beta-Antagonists